| 1. |
WRITING GROUP MEMBERS; Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update:a report from the American Heart Association. Circulation, 2010, 121(7):e46-e215.
|
| 2. |
Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the management of peripheral arterial disease (TASCⅡ). J Vasc Surg, 2007, 45 Suppl S:S5-S67.
|
| 3. |
Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL):multicentre, randomised controlled trial. Lancet, 2005, 366(951):1925-1934.
|
| 4. |
Aihara H, Soga Y, Mii S, et al. Comparison of long-term outcome after endovascular therapy versus bypass surgery in claudication patients with Trans-Atlantic Inter-Society Consensus-ⅡC and D femoropopliteal disease. Circ J, 2014, 78(2):457-464.
|
| 5. |
Met R, Van Lienden KP, Koelemay MJ, et al. Subintimal angioplasty for peripheral arterial occlusive disease:a systematic review. Cardiovasc Intervent Radiol, 2008, 31(4):687-697.
|
| 6. |
Balasubramanian SK, Venkatasubramanian RT, Menon A, et al. Thermal injury prediction during cryoplasty through in vitro characterization of smooth muscle cell biophysics and viability. Ann Biomed Eng, 2008, 36(1):86-101.
|
| 7. |
Spiliopoulos S, Katsanos K, Karnabatidis D, et al. Cryoplasty versus conventional balloon angioplasty of the femoropopliteal artery in diabetic patients:long-term results from a prospective randomized single-center controlled trial. Cardiovasc Intervent Radiol, 2010, 33(5):929-938.
|
| 8. |
Diaz ML, Urtasun F, Barberena J, et al. Cryoplasty versus conven-tional angioplasty in femoropopliteal arterial recanalization:3-year analysis of reintervention-free survival by treatment received. Cardiovasc Intervent Radiol, 2011, 34(5):911-917.
|
| 9. |
Cassese S, Byrne RA, Ott I, et al. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease:a meta-analysis of randomized trials. Circ Cardiovasc Interv, 2012, 5(4):582-589.
|
| 10. |
Fusaro M, Cassese S, Ndrepepa G, et al. Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery:a meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison. Int J Cardiol, 2013, 168(4):4002-4009.
|
| 11. |
Lejay A, Thaveau F, Girsowicz E, et al. Stent evolution for peripheral arterial disease. J Cardiovasc Surg (Torino), 2012, 53(1 Suppl 1):171-179.
|
| 12. |
Wu R, Yao C, Wang S, et al. Percutaneous transluminal angioplasty versus primary stenting in infrapopliteal arterial disease:a meta-analysis of randomized trials. J Vasc Surg, 2014, 59(6):1711-1720.
|
| 13. |
Bosiers M, Peeters P, D, archambeau O, et al. AMS insight-absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia:6-month analysis. Cardiovasc Intervent Radiol, 2009, 32(3):424-435.
|
| 14. |
Dake MD, Ansel GM, Jaff MR, et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease:twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv, 2011, 4(5):495-504.
|
| 15. |
Rastan A, Brechtel K, Krankenberg H, et al. Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents. J Am Coll Cardiol, 2012, 60(7):587-591.
|
| 16. |
Scheinert D, Katsanos K, Zeller T, et al. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease:1-year results from the Achilles trial. J Am Coll Cardiol, 2012, 60(22):2290-2295.
|
| 17. |
Lanckohr C, Torsello G, Scheld H, et al. Drug-eluting stents and perioperative risk-more than matters of the heart? Vasa, 2012, 41(6):410-418.
|
| 18. |
Saxon RR, Dake MD, Volgelzang RL, et al. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endo-prosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol, 2008, 19(6):823-832.
|
| 19. |
Setacci C, De Donato G, Teraa M, et al. ChapterⅣ:treatment of cri-tical limb ischaemia. Eur J Vasc Endovasc Surg, 2011, 42(Suppl 2):S43-S59.
|
| 20. |
Semaan E, Hamburg N, Nasr W, et al. Endovascular management of the popliteal artery:comparison of atherectomy and angioplasty. Vasc Endovascular Surg, 2010, 44(1):25-31.
|
1/5
WeChat